Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Lineage Cell Therapeutics Inc. (LCTX)

1.51   -0.01 (-0.66%) 02-14 16:00
Open: 1.52 Pre. Close: 1.52
High: 1.6 Low: 1.46
Volume: 833,932 Market Cap: 226M
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa multicenter trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also develops Renevia, a facial aesthetics product that is in pivotal clinical trial for the treatment of HIV-associated facial lipoatrophy; ReGlyde, a HyStem product in preclinical development as a device for viscosupplementation, and as a platform for intr

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.602 - 1.61 1.61 - 1.617
Low: 1.443 - 1.451 1.451 - 1.457
Close: 1.498 - 1.511 1.511 - 1.521

Technical analysis

as of: 2020-02-14 4:30:23 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.95     One year: 2.28
Support: Support1: 1.09    Support2: 0.73
Resistance: Resistance1: 1.67    Resistance2: 1.95
Pivot: 1.24
Moving Average: MA(5): 1.51     MA(20): 1.15
MA(100): 0.90     MA(250): 1.05
MACD: MACD(12,26): 0.18     Signal(9): 0.14
Stochastic oscillator: %K(14,3): 77.87     %D(3): 84.14
RSI: RSI(14): 71.69
52-week: High: 1.73  Low: 0.53  Change(%): 18.9
Average Vol(K): 3-Month: 109895  10-Days: 171886

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
LCTX has closed below upper band by 17.9%. Bollinger Bands are 193.1% wider than normal. The large width of the bands suggest high volatility as compared to LCTX's normal range. The bands have been in this wide range for 14 bars. This is a sign that the current trend might continue.

Headline News

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 149.79
Shares Float (M) 107.67
% Held by Insiders 5.67
% Held by Institutions 43.23
Shares Short (K) 6220
Shares Short P. Month (K)

Stock Financials

EPS -0.373
Book Value (p.s.) 0.780
PEG Ratio
Profit Margin
Operating Margin -1247.33
Return on Assets (ttm) -15.3
Return on Equity (ttm) -36.7
Qtrly Rev. Growth -42.3
Gross Profit (p.s.) 0.031
Sales Per Share
EBITDA (p.s.) -0.232
Qtrly Earnings Growth
Operating Cash Flow (M) -32.24
Levered Free Cash Flow (M) -26.78

Stock Valuations

P/E -4.05
P/E Growth Ratio -0.01
P/BV 1.94
P/S 75.50
P/CF -7.02

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio 3
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.